293 related articles for article (PubMed ID: 17228250)
1. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
Hodaie M; Neimat JS; Lozano AM
Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
[TBL] [Abstract][Full Text] [Related]
2. Role of the nigrostriatal dopaminergic neurons in mediating the effect of exogenous L-dopa in Parkinson's disease.
Melamed E
Mt Sinai J Med; 1988 Jan; 55(1):35-42. PubMed ID: 3279303
[No Abstract] [Full Text] [Related]
3. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
4. The dopaminergic nigrostriatal system: development, physiology, disease.
von Bohlen Und Halbach O; Krieglstein K; Schober A; Schulz JB
Cell Tissue Res; 2004 Oct; 318(1):3. PubMed ID: 15340830
[No Abstract] [Full Text] [Related]
5. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)].
MÃnguez-Castellanos A; Escamilla-Sevilla F
Rev Neurol; 2005 Nov 16-30; 41(10):604-14. PubMed ID: 16288424
[TBL] [Abstract][Full Text] [Related]
6. Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
Hirsch EC
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S115-20; discussion S120-1. PubMed ID: 10762138
[TBL] [Abstract][Full Text] [Related]
7. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
Isacson O; Bjorklund LM; Schumacher JM
Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease: biology and aetiology.
Temlett JA
Curr Opin Neurol; 1996 Aug; 9(4):303-7. PubMed ID: 8858189
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
[TBL] [Abstract][Full Text] [Related]
10. Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease.
Elsworth JD; Roth RH
Exp Neurol; 1997 Mar; 144(1):4-9. PubMed ID: 9126143
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and animal studies of Parkinson's disease.
Oertel WH; Kupsch A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
[TBL] [Abstract][Full Text] [Related]
12. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system.
Grothe C; Timmer M
Brain Res Rev; 2007 Apr; 54(1):80-91. PubMed ID: 17229467
[TBL] [Abstract][Full Text] [Related]
13. [Gene therapy and cell transplantation for Parkinson's disease].
Muramatsu S
Rinsho Shinkeigaku; 2005 Nov; 45(11):902-4. PubMed ID: 16447758
[TBL] [Abstract][Full Text] [Related]
14. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
[TBL] [Abstract][Full Text] [Related]
15. Extrastriatal dopamine and Parkinson's disease.
Parent A; Cossette M
Adv Neurol; 2001; 86():45-54. PubMed ID: 11554008
[No Abstract] [Full Text] [Related]
16. New therapeutic approaches to Parkinson's disease including neural transplants.
Kuan WL; Barker RA
Neurorehabil Neural Repair; 2005 Sep; 19(3):155-81. PubMed ID: 16093408
[TBL] [Abstract][Full Text] [Related]
17. Application of ex vivo gene therapy in the treatment of Parkinson's disease.
Raymon HK; Thode S; Gage FH
Exp Neurol; 1997 Mar; 144(1):82-91. PubMed ID: 9126156
[TBL] [Abstract][Full Text] [Related]
18. Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease.
Lang AE; Obeso JA
Ann Neurol; 2004 Jun; 55(6):761-5. PubMed ID: 15174009
[No Abstract] [Full Text] [Related]
19. [Surgical treatment of Parkinson's disease].
Maciaczyk J; Swietaszczyk C; Kasprzak HA
Przegl Lek; 2004; 61(12):1383-8. PubMed ID: 15850334
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of dopamine and Zn2+ on the induction of PC12 cell death and dopamine depletion in the striatum: possible implication in the pathogenesis of Parkinson's disease.
Lo HS; Chiang HC; Lin AM; Chiang HY; Chu YC; Kao LS
Neurobiol Dis; 2004 Oct; 17(1):54-61. PubMed ID: 15350965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
